Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373107 · ClinicalTrials.gov registry record · NA
Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke
A NA study, sponsored by Alvernia University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT06373107: Clinical Trial NA study, sponsored by Alvernia University.
NCT06373107 is a NA study that was terminated before completion, run by Alvernia University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373107, a NA study, was terminated before completion, sponsored by Alvernia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.
Primary Outcome
Measures backward gait velocity
Interventions
- BEHAVIORAL High intensity gait training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Why NCT06373107 stopped before completion
NCT06373107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which High intensity gait training is the first listed.
NCT06373107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06373107 about?
NCT06373107 is a clinical study titled "Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke". The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental ...
What is the current status of trial NCT06373107?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2024-12-01. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT06373107?
The interventions under investigation include: High intensity gait training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06373107?
This trial is sponsored by Alvernia University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06373107's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI